Combination immunotherapy in pleural mesothelioma - International Association for the Study of Lung Cancer

Combination immunotherapy in pleural mesothelioma – International Association for the Study of Lung Cancer

Quoting International Association for the Study of Lung Cancer on LinkedIn:

“Combination immunotherapy in pleural mesothelioma may not necessarily be less toxic for certain patients, according to real-world data published recently in the Journal of Thoracic Oncology. Learn more in ILCN.”

Source: International Association for the Study of Lung Cancer/LinkedIn

cancer immunotherapy International Association for the Study of Lung Cancer Lung cancer Ned McNamee OncoDaily Oncology pleural mesothelioma